Remission

Also known as: Remission phase (qualifier value)

Drug	Drug Name	Drug Description
DB01250	Olsalazine	An anti-inflammatory aminosalicylate used in the treatment of inflammatory bowel disease and ulcerative colitis.
DB06372	Rilonacept	An IL-1 inhibitor used to treat cryopyrin-associated periodic syndrome, a rare hereditary inflammatory disorder.

Drug	Drug Name	Target	Type
DB01250	Olsalazine	Interferon gamma	target
DB01250	Olsalazine	Thiopurine S-methyltransferase	target
DB01250	Olsalazine	Solute carrier family 2, facilitated glucose transporter member 9	transporter
DB01250	Olsalazine	Solute carrier family 22 member 6	transporter
DB01250	Olsalazine	Solute carrier family 22 member 8	transporter
DB01250	Olsalazine	Sodium-dependent phosphate transporter 1	transporter
DB01250	Olsalazine	Sodium/Potassium Transporting ATPase	transporter
DB01250	Olsalazine	Human Cyclooxygenases	target
DB01250	Olsalazine	Xanthine dehydrogenase/oxidase	target
DB06372	Rilonacept	Interleukin-1 beta	target
DB06372	Rilonacept	Interleukin-1 alpha	target
DB06372	Rilonacept	Interleukin-1 receptor antagonist protein	target

Drug	Drug Name	Phase	Status	Count
DB11344	(+)-menthol	2	Active Not Recruiting	1
DB14283	Angelica archangelica root	2	Active Not Recruiting	1
DB01008	Busulfan	2	Recruiting	1
DB15649	Carbomer	2	Active Not Recruiting	1
DB01073	Fludarabine	2	Recruiting	1
DB10344	Ginger	2	Active Not Recruiting	1
DB01202	Levetiracetam	2	Recruiting	1
DB01042	Melphalan	2	Recruiting	1
DB02701	Nicotinamide	2	Active Not Recruiting	1
DB00073	Rituximab	2	Recruiting	1
DB09446	Safflower oil	2	Active Not Recruiting	1
DB08839	Serotonin	2	Completed	1
DB08879	Belimumab	3	Recruiting	1
DB00959	Methylprednisolone	3	Recruiting	1
DB00073	Rituximab	4	Terminated	1